JILLIAN HEYWOOD: Open Payments
NPI 1639476971 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,231 in 147 payments from 14 companies in 2025. Trend: 2023 $396 · 2024 $1,816 · 2025 $2,231
Food & beverage: $2,136Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $495 |
| ABBVIE INC. | 27 | $340 |
| Arcutis Biotherapeutics, Inc. | 33 | $304 |
| Incyte Corporation | 17 | $262 |
| GENZYME CORPORATION | 10 | $206 |
| Verrica Pharmaceuticals Inc. | 14 | $170 |
| UCB, Inc. | 5 | $94 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Journey Medical Corporation | 3 | $71 |
| LEO Pharma Inc. | 3 | $69 |
Products named: TREMFYA, Zoryve, OPZELURA, SKYRIZI, DUPIXENT, YCANTH, RINVOQ, Bimzelx.
Industry payments across CA — which companies pay providers there.
